K Pio G (1+15) Tablet

K Pio G (1+15) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Blue Cross Laboratories Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Glimepiride, Pioglitazone. This drug comes in the form of Tablet. The general packing available for this medicine consists of 10 Tablet and is priced at Rs 17.1 (arround $0.2394 US Dollar)
Generic (Salt) Combination :(Glimepiride+ Pioglitazone)
Pharma Company :Blue Cross Laboratories Ltd.
Brand Label :K Pio G (1+15)
Preparation Type :Tablet
Single Dose :1 Tablet
Composition (Fixed-Dose Combination) :
  • Glimepiride-1 mg
  • Pioglitazone-15 mg
Pack Size/Qty/Vol :10 Tablet
Price Unit :Rs 1.71 INR (arround $0.02394 US Dollar)
Price Pack :Rs 17.1 INR (arround $0.2394 US Dollar)

Drug details for K Pio G (1+15)

Usage: Why is this medication prescribed?

The main active ingredients or salts in K Pio G (1+15) are :

  • Glimepiride-1 mg
  • Pioglitazone-15 mg

Glimepiride
Indication (Prescribed for or used as): Glimepiride is used along with diet and exercise, and sometimes with other medications, to treat type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in the blood). Glimepiride lowers blood sugar by causing the pancreas to produce insulin (a natural substance that is needed to break down sugar in the body) and helping the body use insulin efficiently. This medication will only help lower blood sugar in people whose bodies produce insulin naturally. Glimepiride is not used to treat type 1 diabetes (condition in which the body does not produce insulin and, therefore, cannot control the amount of sugar in the blood) or diabetic ketoacidosis (a serious condition that may occur if high blood sugar is not treated).Over time, people who have diabetes and high blood sugar can develop serious or life-threatening complications, including heart disease, stroke, kidney problems, nerve damage, and eye problems. Taking medication(s), making lifestyle changes (e.g., diet, exercise, quitting smoking), and regularly checking your blood sugar may help to manage your diabetes and improve your health. This therapy may also decrease your chances of having a heart attack, stroke, or other diabetes-related complications such as kidney failure, nerve damage (numb, cold legs or feet; decreased sexual ability in men and women), eye problems, including changes or loss of vision, or gum disease. Your doctor and other healthcare providers will talk to you about the best way to manage your diabetes.

Non-insulin dependent diabetes.

For more details on Glimepiride, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Glimepiride..

Pioglitazone
Indication (Prescribed for or used as): Pioglitazone is used with a diet and exercise program and sometimes with other medications, to treat type 2 diabetes (condition in which the body does not use insulin normally and therefore cannot control the amount of sugar in the blood). Pioglitazone is in a class of medications called thiazolidinediones. It works by increasing the body's sensitivity to insulin, a natural substance that helps control blood sugar levels. Pioglitazone is not used to treat type 1 diabetes (condition in which the body does not produce insulin and, therefore, cannot control the amount of sugar in the blood) or diabetic ketoacidosis (a serious condition that may develop if high blood sugar is not treated).Over time, people who have diabetes and high blood sugar can develop serious or life-threatening complications, including heart disease, stroke, kidney problems, nerve damage, and eye problems.Taking medication(s), making lifestyle changes (e.g., diet, exercise, quitting smoking), and regularly checking your blood sugar may help to manage your diabetes and improve your health. This therapy may also decrease your chances of having a heart attack, stroke, or other diabetes-related complications such as kidney failure, nerve damage (numb, cold legs or feet; decreased sexual ability in men and women), eye problems, including changes or loss of vision, or gum disease. Your doctor and other healthcare providers will talk to you about the best way to manage your diabetes.

Type 2 diabetes mellitus.

For more details on Pioglitazone, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Pioglitazone..

K Pio G (1+15) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :

There are 25 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for K Pio G (1+15), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Glimepiride-1 mg Pioglitazone-15 mg).
Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.

BrandPrice (Rs.)BrandPrice (Rs.)
Amaryl P1 (1+15) 75.55Euglim P (1+15) 27.79
G Tase G (1+15) 27G Tase G (15+1) (Unisearch) 30.58
Gitar G1 (1+15) 42.85Glimiprex PG (1+15) 38.54
Gluconorm PG (1+15) 79Gluconorm PGL (1+15) 61
Mepride P (15+1) 37Ozomet PG (1+15) 61
Path G (1+15) 59.3Pioglit G (15+1) 67
Pioglu G (15+1) 30Piopod G1 (1+15) 57.8
Piopod GM (1+15) 56.5Pioryl (15+1) 54.5
Piotop UD (15+1) 35.04Pioz G (15+1) 65
Pozitiv G1 (1+15) 40.6Riomet Trio (1+15) 77.5
Ronyglim M (1+15) 41.9Triglimisave (1+15) 65
Zipio G (15+1) 20.9Zogli FC (1+15) 151
Zorep (1+15) 40

Search Drug Brands alphabetically